Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression.

Cell Stem Cell. 2017; 
AlvaradoAlvaro G,ThiagarajanPraveena S,Mulkearns-HubertErin E,SilverDaniel J,HaleJames S,AlbanTyler J,TuragaSoumya M,JarrarAwad,ReizesOfer,LongworthMichelle S,VogelbaumMichael A,LathiaJust
Products/Services Used Details Operation
Catalog Antibody The following TLR ligands and inhibitors were obtained from InvivoGen (San Diego, CA, USA): CpG (2 mM), Pam3C (300 ng/mL), PolyI:C(10mg/mL),CLI-095(1mM),andBX795(100nM).LPS(500ng/mL)wasobtainedfromSigma.HMGB1(1mg/mL)wasobtained from GenScript (Piscataway, NJ, USA). Get A Quote

摘要

Tumors contain hostile inflammatory signals generated by aberrant proliferation, necrosis, and hypoxia. These signals are sensed and acted upon acutely by the Toll-like receptors (TLRs) to halt proliferation and activate an immune response. Despite the presence of TLR ligands within the microenvironment, tumors progress, and the mechanisms that permit this growth remain largely unknown. We report that self-renewing cancer stem cells (CSCs) in glioblastoma have low TLR4 expression that allows them to survive by disregarding inflammatory signals. Non-CSCs express high levels of TLR4 and respond to ligands. TLR4 signaling suppresses CSC properties by reducing retinoblastoma binding protein 5 (RBBP5), whi... More

关键词

RBBP5,TLR4,cancer stem cells,glioblastoma,innate immunity,pluripotency transcription fac
XML 地图